Skip to main content

Advertisement

Log in

Hutchinson–Gilford progeria syndrome as a model for vascular aging

  • Review Article
  • Published:
Biogerontology Aims and scope Submit manuscript

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a premature aging disorder caused by a de novo genetic mutation that leads to the accumulation of a splicing isoform of lamin A termed progerin. Progerin expression alters the organization of the nuclear lamina and chromatin. The life expectancy of HGPS patients is severely reduced due to critical cardiovascular defects. Progerin also accumulates in an age-dependent manner in the vascular cells of adults that do not carry genetic mutations associated with HGPS. The molecular mechanisms that lead to vascular dysfunction in HGPS may therefore also play a role in vascular aging. The vascular phenotypic and molecular changes observed in HGPS are strikingly similar to those seen with age, including increased senescence, altered mechanotransduction and stem cell exhaustion. This article discusses the similarities and differences between age-dependent and HGPS-related vascular aging to highlight the relevance of HGPS as a model for vascular aging. Induced pluripotent stem cells derived from HGPS patients are suggested as an attractive model to study vascular aging in order to develop novel approaches to treat cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

EC:

Endothelial cell

ECM:

Extracellular matrix

EPC:

Endothelial progenitor cell

ESC:

Embryonic stem cell

HGPS:

Hutchinson–Gilford progeria syndrome

iPSC:

Induced pluripotent stem cell

MSC:

Mesenchymal stem cell

NF:

Nuclear factor

NO:

Nitric oxide

ROS:

Reactive oxygen species

VSMC:

Vascular smooth muscle cell

References

Download references

Acknowledgments

We thank Dr. Gerardo Ferbeyre (Université de Montréal) for reviewing this manuscript, and for his insightful comments and discussion. We also thank Professor Gaétan Laroche (Université Laval and Centre de recherche du CHU de Québec) and William L. Stanford (Ottawa Hospital Research Institute and University of Ottawa) for useful discussions. We thank the Canadian Stem Cell Network (JB, AG and CH), Pfizer Ltd and Pfizer Canada Inc. (See the Potential postdoctoral fellowship awarded to CH), the Canadian Institutes of Health Research (MOP-142285), Saint-Gobain Ceramics & Plastics Inc., the ThéCell Network and the Centre québécois sur les matériaux fonctionnels (CQMF) strategic cluster of the Fonds de recherche du Québec—Nature et technologies for their financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Corinne A. Hoesli.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brassard, J.A., Fekete, N., Garnier, A. et al. Hutchinson–Gilford progeria syndrome as a model for vascular aging. Biogerontology 17, 129–145 (2016). https://doi.org/10.1007/s10522-015-9602-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10522-015-9602-z

Keywords

Navigation